View Post

Stopping tumor cell movement halts cancer spread

In In The News by Barbara Jacoby

By: Catharine Paddock PhD From: medicalnewstoday.com New insights into how tumor cells move could greatly assist in developing treatments to prevent the spread of cancer Using an experimental model, scientists from the University of Minnesota in Minneapolis stopped cancer cells from spreading, even after the cells had altered their mode of movement. The chances of eliminating cancer are much higher …

View Post

Student borrowers with cancer can now pause their payments

In In The News by Barbara Jacoby

By: Annie Nova From: cnbc.com Borrowers are now exempt from their federal student loan payments throughout their treatments for cancer and then for six months afterward. Interest will not accrue during the postponement. More than 70,000 adults between the ages of 15 and 39 are diagnosed with cancer in the United States each year, and student debt is increasingly an …

View Post

Cancer: Brain-derived compounds show surprising benefits

In In The News by Barbara Jacoby

Source: Veterans Affairs Research Communications From: sciencedaily.com A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice. The surprising discovery, …

View Post

Could this giant 2,500-year-old fungus hold the cure to cancer?

In In The News by Barbara Jacoby

By: Bryan Nelson From: mnn.com Researchers have just discovered that a giant fungus first found 25 years ago in a forest on Michigan’s Upper Peninsula has gotten much, much larger, and the secret to its phenomenal growth might hold the cure to cancer, reports Phys.org. When it was first discovered, the mammoth mushroom, an Armillaria gallica specimen (also known as …

View Post

Long Haul for Breast Cancer Survivors: Disease Can Return After 20 Years

In In The News by Barbara Jacoby

From: healthline.com New research shows that long-term endocrine therapy can reduce the risk of breast cancer recurrence in the long term. But side effects keep some women from taking it. Like many breast cancer survivors, Julie Barthels wonders if the disease will return. “My breast cancer came silently, without my knowledge. How do I know what is silently growing inside …

View Post

Virtual Reality Experience for Chemotherapy Patients Earns 2018 Magnet Prize®

In In The News by Barbara Jacoby

By: Hiran Ratnayake From: prnewswire.com Prestigious Award from American Nurses Credentialing Center Recognizes Christiana Care Project as a Stellar Example of Innovation to Make Cancer Treatment Easier on Patients Christiana Care Health System has won the prestigious 2018 Magnet Prize® from the American Nurses Credentialing Center (ANCC) for using virtual reality technology to improve patients’ experience during chemotherapy at Christiana …

View Post

Susan G. Komen® Announces 2019 3-Day® Schedule

In In The News by Barbara Jacoby

From: prnewswire.com Life-changing series of 60-mile walks opens registration with empowering ‘Commit 3 Days’ campaign Susan G. Komen®, the world’s largest breast cancer organization, is proud to announce the 2019 schedule for its annual 3-Day® Series – the greatest distance you can go in the fight against breast cancer® – 60 miles in 3 days. As one of the organization’s …

View Post

Breast cancer screening: How does it truly impact survival?

In In The News by Barbara Jacoby

By: Maria Cohut From: medicalnewstoday.com In the medical world, there is an ongoing debate about the extent to which regularly screening for breast cancer actually improves a person’s chances of survival if cancer is detected. New research tries to settle that debate.   Breast cancer is the most common type of cancer diagnosed in women, and the National Cancer Institute …

View Post

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy

In In The News by Barbara Jacoby

Source: esmo.org From: news-medical.net Treatment with the cyclin dependent kinase (CDK) 4/6 inhibitor palbociclib achieves a clinically meaningful improvement in overall survival in patients with hormone receptor positive (HR+) human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer that has relapsed or progressed on hormonal therapy, according to the final analysis of overall survival results from the PALOMA-3 study …

View Post

Moths and magnets could save lives

In In The News by Barbara Jacoby

Source: Rice University SUMMARY: Rice University bioengineers have combined a virus that infects moths with magnetic nanoparticles to create a potential new therapy for inherited genetic diseases like muscular dystrophy, sickle cell, cystic fibrosis, spinal muscular atrophy and some forms of cancer. A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes …